Composition comprising a polymer and a bioactive agent and method of preparing thereof

1. A composition comprising a bacteriophage and a substrate, wherein the bacteriophage is adsorbed on the substrate and wherein the substrate includes at least one salt, wherein the substrate is dispersed in a polymer, and wherein the polymer is selected from a polymer group consisting of:

(1) a poly (ester amide urea) wherein at least one diol, at least one diacid, and at least one amino acid are linked together through an ester bond, an amide bond, and a urea bond,

(2) a poly (ester urethane urea) wherein at least one diol and at least one amino acid are linked together through an ester bond, a urethane bond, and a urea bond,

(3) a poly (ester amide urethane urea) wherein at least one diol, at least one diacid, and at least one amino acid are linked together through an ester bond, an amide bond, a urethane bond, and a urea bond,

(4) a poly (ester amide urethane) wherein at least one diol, at least one diacid, and at least one amino acid are linked together through an ester bond, an amide bond, and a urethane bond,

(5) a poly (ester urea) wherein at least one diol and at least one amino acid are linked together through an ester bond and a urea bond, and

(6) a poly (ester urethane) wherein at least one diol and at least one amino acid are linked together through an ester bond and a urethane bond,

wherein

the at least one diol is a compound of formula:

HO—R 1 —OH, R 1 is chosen from C 1 -C 12 alkylene optionally interrupted by at least one oxygen, C 3 -C 8 cycloalkylene, C 3 -C 10 cycloalkylalkylene,

the at least one diacid is a compound of formula:

HO—(CO)—R 3 —(CO)—OH, R 3 is C 1 -C 12 alkylene,

the at least one amino acid is chosen from a naturally occurring amino acid and non-naturally occurring amino acid.

2. The composition of claim 1 , wherein the polymer is a poly (ester amide urea) comprising the following two blocks with random distribution thereof:

wherein

the ratio of l:m ranges from 0.01:0.99 to 0.99:0.01, l+m=1,

R 1 is chosen from C 1 -C 12 alkylene optionally interrupted by at least one oxygen, C 3 -C 8 cycloalkylene, C 3 -C 10 cycloalkylalkylene,

R 3 is C 1 -C 12 alkylene,

R 2 and R 4 are independently chosen from the side chains of L- and D-amino acids so that the carbon to which R 2 or R 4 is attached has L or D chirality.

3. The composition of claim 1 , wherein the polymer is poly (ester urethane urea) comprising the following two blocks with random distribution thereof:

wherein

the ratio of l:m ranges from 0.01:0.99 to 0.99:0.01, l+m=1,

R 1 and R 5 are independently chosen from C 1 -C 12 alkylene optionally interrupted by at least one oxygen, C 3 -C 8 cycloalkylene, C 3 -C 10 cycloalkylalkylene,

and

R 2 and R 4 are independently chosen from the side chains of L- and D-amino acids so that the carbon to which R 2 or R 4 is attached has L or D chirality.

4. The composition of claim 1 , wherein the polymer is poly (ester amide urethane urea) comprising the following three blocks with random distribution thereof:

wherein

the ratio of l:m:k ranges from 0.05:0.05:0.90 to 0.90:0.05:0.05, l+m+k=1,

R 1 and R 5 are independently chosen from C 1 -C 12 alkylene optionally interrupted by at least one oxygen, C 3 -C 8 cycloalkylene, C 3 -C 10 cycloalkylalkylene,

R 3 is C 1 -C 12 alkylene, and

R 2 and R 4 are independently chosen from the side chains of L- and D-amino acids so that the carbon to which R 2 or R 4 is attached has L or D chirality.

5. The composition of claim 1 , wherein the polymer is (ester amide urethane) comprising the following two blocks with random distribution thereof:

wherein

the ratio of l:m ranges from 0.01:0.99 to 0.99:0.01, l+m=1,

R 1 and R 5 are independently chosen from C 1 -C 12 alkylene optionally interrupted by at least one oxygen, C 3 -C 8 cycloalkylene, C 3 -C 10 cycloalkylalkylene,

R 3 is C 1 -C 12 alkylene, and

R 2 and R 4 are the same and selected from the side chains of L- and D-amino acids so that the carbon to which R 2 or R 4 is attached has L or D chirality.

6. The composition of claim 1 , wherein the polymer is a first polymer, the composition further comprising a second polymer blended with the first polymer, the second polymer differing from the first polymer, wherein the second polymer is selected from the polymer group or is a poly (ester amide) wherein at least one diol, at least one diacid and at least one amino acid are linked together through an ester bond and an amide bond and wherein the at least one diol is a compound of formula:

HO—R 1 —OH, R 1 is chosen from C 1 -C 12 alkylene optionally interrupted by at least one oxygen, C 3 -C 8 cycloalkylene, C 3 -C 10 cycloalkylalkylene,

the at least one diacid is a compound of formula:

HO—(CO)—R 3 —(CO)—OH, R 3 is C 1 -C 12 alkylene,

the at least one amino acid is chosen from a naturally occurring amino acid and non-naturally occurring amino acid.

7. The composition of claim 6 , wherein the first polymer is a poly(ester urea) comprising repeating units of:

and the second polymer is a poly(ester amide) comprising repeating units of:

wherein R 1 is chosen from C 1 -C 12 alkylene optionally interrupted by at least one oxygen, C 3 -C 8 cycloalkylene, C 3 -C 10 cycloalkylalkylene,

R 3 is C 1 -C 12 alkylene,

R 2 and R 4 are independently chosen from the side chains of L- and D-amino acids so that the carbon to which R 2 or R 4 is attached has L or D chirality.

8. The composition of claim 1 , wherein the bacteriophage is a bioactive agent, the composition further comprising at least one other bioactive agent chosen from an antiseptic, an anti-infective, a bacteriophage-derived product, endolysins, a phage protein, a phage enzyme, an antibiotic, an antibacterial, an antiprotozoal agent, an antiviral, an analgesic, an anti-inflammatory agent, a steroid, a non-steroidal anti-inflammatory agent, prednisolone, diclofenac sodium, a COX-2 inhibitor, an antineoplastic agent, a contraceptive, a central nervous system (CNS) active drug, an hormone, a vaccine, and mixtures thereof, wherein the bacteriophage-derived product is selected from endolysins, EPS depolymerases, depolymerases, hydrolases, lyases, phage enzymes, phage early proteins, phage holins, and mixtures thereof.

9. The composition of claim 6 , wherein the bacteriophage is a bioactive agent, the composition further comprising at least one other bioactive agent chosen from an antiseptic, an anti-infective, a bacteriophage-derived product, endolysins, a phage protein, a phage enzyme, an antibiotic, an antibacterial, an antiprotozoal agent, an antiviral, an analgesic, an anti-inflammatory agent, a steroid, a non-steroidal anti-inflammatory agent, prednisolone, diclofenac sodium, a COX-2 inhibitor, an antineoplastic agent, a contraceptive, a central nervous system (CNS) active drug, an hormone, a vaccine, and mixtures thereof, wherein the bacteriophage-derived product is selected from endolysins, EPS depolymerases, depolymerases, hydrolases, lyases, phage enzymes, phage early proteins, phage holins, and mixtures thereof.

10. A method of treating a patient having a wound in need thereof comprising inserting into the wound or covering the wound with a composition of claim 1 .

11. A process for preparing the composition of claim 1 , comprising

a. mixing a salt of a diester and at least one base in water,

b. mixing at least two bis-electrophiles in an organic solvent,

c. mixing the mixtures from step a and b and stirring vigorously enough to cause interfacial polycondensation to produce the polymer,

d. obtaining an organic layer including the polymer dissolved in the organic solvent,

e. preparing the bacteriophages adsorbed on the substrate at any time before, during or after steps a to d,

f. mixing the bacteriophages adsorbed on the substrate with the organic layer to obtain a mixture;

g. casting the mixture from step f onto a hydrophobic surface; and

h. removing the organic solvent to obtain a film,

wherein the at least two bis-electrophiles is

a mixture of diacid chloride of formula Cl(CO)—R 3 —(CO)Cl and tri-phosgene with molar ratio of the diacid chloride:triphosgene ranges from 0.95:(0.05/3) to 0.05:(0.95/3) for preparing poly(ester amide urea), or

a mixture of dichloroformate of formula Cl(CO)—O—R 5 —O—(CO)Cl and triphosgene with molar ratio of the dichloroformate:triphosgene ranging from 0.95:(0.05/3) to 0.05:(0.95/3) for preparing poly(ester urethane urea), or

a mixture of diacid chloride of formula Cl(CO)—R 3 —(CO)Cl, di-chloroformate of formula Cl(CO)—O—R 5 —O—(CO)Cl, and tri-phosgene with molar ratio of the diacid chloride:dichloroformate:triphosgene ranging from 0.90:0.05:(0.05/3) to 0.05:0.05:(0.90/3) for preparing poly(ester amide urethane urea), or

a mixture of diacid chloride of formula Cl(CO)—R 3 —(CO)Cl and di-chloroformate of formula Cl(CO)—O—R 5 —O—(CO)Cl with molar ratio of the diacid chloride:di-chloroformate ranging from 0.95:0.05 to 0.05:0.95 for preparing poly(ester amide urethane), the diester has the following formula

wherein

R 1 and R 5 are independently chosen from C 1 -C 12 alkylene optionally interrupted by at least one oxygen, C 3 -C 8 cycloalkylene, C 3 -C 10 cycloalkylalkylene,

R 3 is C 1 -C 12 alkylene, and

R 2 and R 4 are the same and selected from the side chains of L- and D-amino acids so that the carbon to which R 2 or R 4 is attached has L or D chirality.

12. The process of claim 11 , wherein removing the organic solvent includes evaporating the organic solvent.

13. A process for preparing the composition of claim 2 comprising:

a. mixing triphosgene, diacid HO(CO)—R 3 —(CO)OH, and at least one organic base in an organic solvent, wherein R 3 is C 1 -C 12 alkylene,

b. mixing a salt of a diester and at least one base in water,

c. mixing the mixtures from step a and b and stirring vigorously enough to cause interfacial polycondensation to produce the polymer,

d. obtaining an organic layer including the polymer dissolved in the organic solvent,

e. preparing the bacteriophages adsorbed on the substrate at any time before, during or after steps a to d,

f. mixing the bacteriophages adsorbed on the substrate with the organic layer to obtain a mixture;

g. casting the mixture from step f onto a hydrophobic surface; and

h. removing the organic solvent to obtain a film,

wherein the diester has the following formula:

wherein

R 1 is chosen from C 1 -C 12 alkylene optionally interrupted by at least one oxygen, C 3 -C 8 cycloalkylene, C 3 -C 10 cycloalkylalkylene,

R 3 is C 1 -C 12 alkylene; and

R 2 and R 4 are independently chosen from the side chains of L- and D-amino acids such that the carbon to which R 2 or R 4 is attached has L or D chirality.

14. A process for preparing the composition of claim 3 comprising

a. mixing triphosgene, diol HO—R 5 —OH, and at least one organic base in an organic solvent,

b. mixing a salt of a diester and at least one base in water,

c. mixing the mixtures from step a and b and stirring vigorously enough to cause interfacial polycondensation to produce the polymer, and

d. obtaining an organic layer including the polymer dissolved in the organic solvent,

e. preparing the bacteriophages adsorbed on the substrate at any time before, during or after steps a to d,

f. mixing the bacteriophages adsorbed on the substrate with the organic layer to obtain a mixture;

g. casting the mixture from step f onto a hydrophobic surface; and

h. removing the organic solvent to obtain a film,

wherein

the diester has the following formula:

wherein

R 1 and R 5 are independently chosen from C 1 -C 12 alkylene optionally interrupted by at least one oxygen, C 3 -C 8 cycloalkylene, C 3 -C 10 cycloalkylalkylene,

and

R 2 and R 4 are independently chosen from the side chains of L- and D-amino acids such that the carbon to which R 2 or R 4 is attached has L or D chirality.

15. A process for preparing the composition of claim 1 wherein the polymer is a poly (ester urea) comprising repeating units of

the process comprising

a. mixing a salt of a diester and at least one base in water,

b. mixing triphosgene in an organic solvent,

c. mixing the mixtures from step a and b and stirring vigorously enough to cause interfacial polycondensation to produce the polymer, and

d. obtaining an organic layer including the polymer dissolved in the organic solvent,

e. preparing the bacteriophages adsorbed on the substrate at any time before, during or after steps a to d,

f. mixing the bacteriophages adsorbed on the substrate with the organic layer to obtain a mixture;

g. casting the mixture from step f onto a hydrophobic surface; and

h. removing the organic solvent to obtain a film,

wherein

the diester has the following formula:

wherein

R 1 is chosen from C 1 -C 12 alkylene optionally interrupted by at least one oxygen, C 3 -C 8 cycloalkylene, C 3 -C 10 cycloalkylalkylene,

and

R 2 and R 4 are independently chosen from the side chains of L- and D-amino acids such that the carbon to which R 2 or R 4 is attached has L or D chirality.

16. The composition of claim 1 , wherein the at least one salt is inorganic.

17. The composition of claim 16 , wherein the at least one salt is chosen from calcium salts, magnesium salts, strontium salts, and barium salts.

18. The composition of claim 16 , wherein the at least one salt is chosen from calcium carbonate, calcium phosphate, and magnesium carbonate.

19. The composition of claim 16 , wherein the at least one salt is a mixture of calcium carbonate and magnesium carbonate.

20. A composition comprising a bacteriophage and a substrate, wherein the bacteriophage is adsorbed on the substrate and wherein the substrate includes at least one salt, wherein the composition is in the form of a dry powder.

21. A process for preparing the composition of claim 20 , comprising

mixing and incubating the at least one salt and at least one bacteriophage;

filtrating the obtained suspension to obtain the at least one bacteriophage adsorbed on wet solid product; and

drying the obtained wet solid product through at least one of vacuum drying, freeze drying, lyophilization, or spray-drying.

22. The process of claim 21 , further comprising washing the obtained wet solid product with saline solution prior to drying.

23. A composition comprising at least one bacteriophage and at least one substrate, wherein the bacteriophage is adsorbed on the substrate and wherein the at least one substrate includes at least one salt, wherein the at least one salt is a mixture of calcium carbonate and magnesium carbonate.